Women following the retatrutide dose schedule may benefit from planning dose escalations to avoid the luteal phase of their menstrual cycle, when GI sensitivity tends to be highest
Regular follow-up visits and health monitoring ensure you stay on the right path toward maintaining optimal wellness
Evidence synthesis: We integrate RCT evidence on weight and metabolic outcomes with exploratory findings on reproductive outcomes, highlighting key effect modifiers (baseline obesity/IR phenotype, concomitant metformin, and follow-up window)
People taking GLP-1 medications typically consume 1639% fewer calories than before treatment because digestion slows and food noise decreases
Heres What We Know A recent question from someone with inflammatory arthritis who saw improvement while using a GLP-1 agonist brings up an interesting topic
Whether you are navigating the complexities of GLP-1 medications or seeking a natural path to food freedom, you dont have to do it alone